BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16184340)

  • 1. Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.
    Ruggieri M; Avolio C; Scacco S; Pica C; Lia A; Zimatore GB; Papa S; Livrea P; Trojano M
    J Neurol; 2006 Feb; 253(2):231-6. PubMed ID: 16184340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
    Hao JH; Yu M; Liu FT; Newland AC; Jia L
    Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
    Sharief MK; Douglas M; Noori M; Semra YK
    J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
    Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate.
    Aktas O; Ari N; Rieks M; Hoffmann V; Schimrigk S; Przuntek H; Pöhlau D
    Acta Neurol Scand; 2001 Nov; 104(5):266-70. PubMed ID: 11696019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis.
    Zhang L; Xing D; Chen M
    Apoptosis; 2008 Jul; 13(7):950-8. PubMed ID: 18500555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate.
    Rieks M; Hoffmann V; Aktas O; Juschka M; Spitzer I; Brune N; Schimrigk S; Przuntek H; Pöhlau D
    Eur Neurol; 2003; 50(4):200-6. PubMed ID: 14634263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.
    Arbour N; Rastikerdar E; McCrea E; Lapierre Y; Dörr J; Bar-Or A; Antel JP
    Mult Scler; 2005 Dec; 11(6):652-7. PubMed ID: 16320724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent.
    Burek M; Maddika S; Burek CJ; Daniel PT; Schulze-Osthoff K; Los M
    Oncogene; 2006 Apr; 25(15):2213-22. PubMed ID: 16288204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
    Perkins C; Kim CN; Fang G; Bhalla KN
    Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadmium-induced apoptosis through the mitochondrial pathway in rainbow trout hepatocytes: involvement of oxidative stress.
    Risso-de Faverney C; Orsini N; de Sousa G; Rahmani R
    Aquat Toxicol; 2004 Aug; 69(3):247-58. PubMed ID: 15276330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between the Bcl-2/Bax Proteins and the Mitochondria-Mediated Apoptosis Pathway in the Differentiation of Adipose-Derived Stromal Cells into Neurons.
    Wang Q; Zhang L; Yuan X; Ou Y; Zhu X; Cheng Z; Zhang P; Wu X; Meng Y; Zhang L
    PLoS One; 2016; 11(10):e0163327. PubMed ID: 27706181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
    Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
    Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells.
    Ragheb S; Abramczyk S; Lisak D; Lisak R
    Mult Scler; 2001 Feb; 7(1):43-7. PubMed ID: 11321193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization.
    Armstrong JS; Steinauer KK; French J; Killoran PL; Walleczek J; Kochanski J; Knox SJ
    Exp Cell Res; 2001 Jan; 262(2):170-9. PubMed ID: 11139341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic Bax.
    Hippe D; Weber A; Zhou L; Chang DC; Häcker G; Lüder CG
    J Cell Sci; 2009 Oct; 122(Pt 19):3511-21. PubMed ID: 19737817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c.
    Ghavami S; Mutawe MM; Hauff K; Stelmack GL; Schaafsma D; Sharma P; McNeill KD; Hynes TS; Kung SK; Unruh H; Klonisch T; Hatch GM; Los M; Halayko AJ
    Biochim Biophys Acta; 2010 Apr; 1803(4):452-67. PubMed ID: 20045437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-mediated apoptosis in patients with adenocarcinoma of the breast: Correlation with histological grade and menopausal status.
    Vinothini G; Murugan RS; Nagini S
    Breast; 2011 Feb; 20(1):86-92. PubMed ID: 20829044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
    Boziki M; Lagoudaki R; Melo P; Kanidou F; Bakirtzis C; Nikolaidis I; Grigoriadou E; Afrantou T; Tatsi T; Matsi S; Grigoriadis N
    J Neurol Sci; 2019 Jun; 401():43-50. PubMed ID: 31009931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.